Ullman Presents on Cannabis Regulations to University of Colorado Grad Students
May 4, 2023 | Cannabis | Compliance Investigations & White Collar

On May 1, Marc Ullman co-presented a virtual lecture to graduate students enrolled in the Masters in Pharmaceutical Sciences and Cannabis Science & Medicine Graduate Certificate program at Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado. The students are taking the course, Legal & Regulatory Issues in Cannabis Science & Medicine.

Marc discussed

Read More
Hardy on Panel for ABA TIPS & YLD Section Conference
April 27, 2023 | Cannabis | Employment & Labor

The Tort Trial & Insurance Practice Section and the Young Lawyers Division of the American Bar Association will host the first joint TIPS & YLD Section Conference, May 3-6, in New York City.

On May 4, Tamika Hardy will serve on the panel, Cannabis in the Workplace: Cultivation, Accommodation or Deprivation. The program will cover employment

Read More
Lunch and Learn Series: New Employment Laws and Regulations Regarding Marijuana in the Workplace
October 20, 2022 | Cannabis | Health Services

Please join us for the November Lunch and Learn as Rivkin Radler Partners John Diviney and Tamika Hardy discuss the following topics:

  • New State laws – New York Marijuana Regulation and Taxation Act, New York Labor Law Section 201-D, New York Human Rights Law, New York Penal Law, New York City Administrative Code
  • Pre-employment
Read More
Ullman Weighs In on FDA Warnings and the Delta-8 THC Market
May 16, 2022 | Cannabis

Ullman was cited in the Natural Products Insider article “Lawyers skeptical FDA warning letters will chill delta-8 THC market.”

The article discusses the effect of the recent rash of FDA warning letters on delta-8 THC products. The warning letters note that delta-8 THC is not an approved treatment for medical conditions.

Asked whether the warning

Read More
Ullman Quoted in Article on FDA’s Enforcement Discretion for CBD
April 26, 2022 | Compliance Investigations & White Collar | Cannabis

Marc Ullman was quoted in the Natural Products Insider article, “FDA written enforcement discretion on CBD unlikely.”

The article discusses how the FDA is unlikely to issue a formal policy of enforcement discretion for CBD-containing products marketed as dietary supplements.

Ullman doesn’t believe the agency would issue a CBD enforcement discretion policy similar to NAC.

Read More
Hardy Quoted in Article on Testing for Marijuana
October 22, 2021 | Cannabis | Employment & Labor

Tamika Hardy was quoted in the Newsday article, “Employers can no longer test most job seekers for marijuana, NY says.”

New York legalized recreational marijuana earlier this year and now, most employers cannot penalize employees for off-hour marijuana use.

Hardy stated, “With certain exceptions, they can’t test employees for cannabis, either, under recent Department of

Read More
Hardy Speaks at Panel on Marijuana Regulation and Taxation Act
July 22, 2021 | Cannabis | Employment & Labor

On July 21, 2021, Tamika Hardy spoke at the Employment & NY Marijuana Legalization (MRTA) panel, presented by the Brooklyn branch of the NAACP.

The Brooklyn NAACP’s Justice Reform and Legal Redress Committees discussed the New York legalization of cannabis as it relates to employment.

Hardy discussed what recreational cannabis legalization means in the employment

Read More
Shapiro Quoted on CBD Warning Letters in Vitamin Retailer
March 29, 2021 | Cannabis | Compliance Investigations & White Collar

Steven Shapiro was quoted in the Vitamin Retailer article, “FDA Warns Selling of Topical CBD Products Violates FD&C Act.”

The FDA has issued warning letters to two companies addressing the illegal marketing of unapproved drugs labeled as containing CBD.

Shapiro questions the letters as neither discussed the potential to use CBD as an inactive ingredient

Read More
Ullman Speaks at Natural Products Insider Webinar
October 6, 2020 | Cannabis

On September 30, Marc Ullman spoke at the Natural Products Insider webinar “Hemp Evolution: Surviving the imminent regulatory shockwave.”

The presentation discussed mitigating legal risks and thriving in the multi-billion dollar hemp phytocannabinoid market.

The video is still available to view. Click here to register and watch.

Read More
Ullman Speaks with NutraIngredients-USA
August 26, 2020 | Health Services | Cannabis

Marc Ullman was quoted in a NutraIngredients-USA article, “AHPA event aims to guide CBD industry.”

The article discusses how products containing cannabidiol (CBD) represent a rapidly growing yet uncertain market segment, with those in the industry often finding themselves with more questions than answers.

Click here to read the full article.

Read More
Next Page

Get legal updates and news delivered to your inbox